Cargando…

Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations

Vaccination is the most effective tool available for fighting the spread of COVID-19. Recently, emerging variants of SARS-CoV-2 have led to growing concerns about increased transmissibility and decreased vaccine effectiveness. Currently, many vaccines are approved for emergency use and more are unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Helmy, Sally A., El-Morsi, Rasha M., Helmy, Soha A.M., El-Masry, Soha M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452404/
https://www.ncbi.nlm.nih.gov/pubmed/36097606
http://dx.doi.org/10.1016/j.jddst.2022.103762
_version_ 1784784911105785856
author Helmy, Sally A.
El-Morsi, Rasha M.
Helmy, Soha A.M.
El-Masry, Soha M.
author_facet Helmy, Sally A.
El-Morsi, Rasha M.
Helmy, Soha A.M.
El-Masry, Soha M.
author_sort Helmy, Sally A.
collection PubMed
description Vaccination is the most effective tool available for fighting the spread of COVID-19. Recently, emerging variants of SARS-CoV-2 have led to growing concerns about increased transmissibility and decreased vaccine effectiveness. Currently, many vaccines are approved for emergency use and more are under development. This review highlights the ongoing advances in the design and development of different nano-based vaccine platforms. The challenges, limitations, and ethical consideration imposed by these nanocarriers are also discussed. Further, the effectiveness of the leading vaccine candidates against all SARS-CoV-2 variants of concern are highlighted. The review also focuses on the possibility of using an alternative non-invasive routes of vaccine administration using micro and nanotechnologies to enhance vaccination compliance and coverage.
format Online
Article
Text
id pubmed-9452404
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-94524042022-09-08 Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations Helmy, Sally A. El-Morsi, Rasha M. Helmy, Soha A.M. El-Masry, Soha M. J Drug Deliv Sci Technol Review Article Vaccination is the most effective tool available for fighting the spread of COVID-19. Recently, emerging variants of SARS-CoV-2 have led to growing concerns about increased transmissibility and decreased vaccine effectiveness. Currently, many vaccines are approved for emergency use and more are under development. This review highlights the ongoing advances in the design and development of different nano-based vaccine platforms. The challenges, limitations, and ethical consideration imposed by these nanocarriers are also discussed. Further, the effectiveness of the leading vaccine candidates against all SARS-CoV-2 variants of concern are highlighted. The review also focuses on the possibility of using an alternative non-invasive routes of vaccine administration using micro and nanotechnologies to enhance vaccination compliance and coverage. Elsevier B.V. 2022-10 2022-09-08 /pmc/articles/PMC9452404/ /pubmed/36097606 http://dx.doi.org/10.1016/j.jddst.2022.103762 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Helmy, Sally A.
El-Morsi, Rasha M.
Helmy, Soha A.M.
El-Masry, Soha M.
Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations
title Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations
title_full Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations
title_fullStr Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations
title_full_unstemmed Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations
title_short Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations
title_sort towards novel nano-based vaccine platforms for sars-cov-2 and its variants of concern: advances, challenges and limitations
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452404/
https://www.ncbi.nlm.nih.gov/pubmed/36097606
http://dx.doi.org/10.1016/j.jddst.2022.103762
work_keys_str_mv AT helmysallya towardsnovelnanobasedvaccineplatformsforsarscov2anditsvariantsofconcernadvanceschallengesandlimitations
AT elmorsirasham towardsnovelnanobasedvaccineplatformsforsarscov2anditsvariantsofconcernadvanceschallengesandlimitations
AT helmysohaam towardsnovelnanobasedvaccineplatformsforsarscov2anditsvariantsofconcernadvanceschallengesandlimitations
AT elmasrysoham towardsnovelnanobasedvaccineplatformsforsarscov2anditsvariantsofconcernadvanceschallengesandlimitations